Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks - Report - MDSpire

Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks

  • By

  • Joe B. B. Silva

  • Han-Chih T. Hsieh

  • Chanelle J. Howe

  • Stefan Gravenstein

  • Laura A. Reich

  • Andrew R. Zullo

  • June 1, 2026

  • 0 min

Share

Timely and Aggressive Antiviral Prophylaxis During Influenza Outbreaks in Long-Term Care Facilities

Overview

This study examines the impact of antiviral chemoprophylaxis strategies on mortality and hospitalization risks during influenza outbreaks in nursing homes. It emphasizes the importance of rapid and widespread administration of oseltamivir to eligible residents.

Background

Influenza outbreaks in nursing homes pose significant risks to older adults, leading to increased morbidity and mortality. The CDC and IDSA recommend prompt antiviral prophylaxis to mitigate the spread of influenza in these settings. Despite strong recommendations, the optimal coverage and timing for effective chemoprophylaxis remain unclear.

Data Highlights

This observational study utilized electronic health record data from 12 US nursing home corporations from September 1, 2018, to May 31, 2022, to analyze the effects of antiviral chemoprophylaxis strategies.

Key Findings

  • Antiviral chemoprophylaxis with oseltamivir was recommended for all non-ill residents during outbreaks.
  • High-quality evidence on optimal coverage thresholds and timing for chemoprophylaxis is lacking.
  • Intensive chemoprophylaxis (≥70% of eligible residents within 2 days) was associated with lower 14-day hospitalization risks.
  • Prior studies showed varying coverage rates (20%-100%) and initiation delays (2-10 days) in previous outbreaks.
  • The study followed STROBE guidelines for observational research reporting.

Clinical Implications

Healthcare professionals should prioritize rapid initiation of antiviral chemoprophylaxis in nursing homes during influenza outbreaks. Understanding the importance of achieving high coverage rates may assist in reducing hospitalization risks among residents.

Conclusion

The study highlights the need for timely and aggressive antiviral strategies to control influenza outbreaks in nursing homes, emphasizing the potential benefits of high coverage and rapid administration.

Related Resources & Content

  1. CDC, Viral Respiratory Pathogens Toolkit for Nursing Homes, 2023 -- Guidance for Influenza Outbreaks
  2. JAMA Internal Medicine, Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks, 2026 -- Study on Chemoprophylaxis Strategies
  3. PubMed, Evaluation of Influenza Antiviral Prophylaxis for Long-term Care Residents: A Systematic Review and Meta-Analysis, 2026 -- Review of Antiviral Efficacy
  4. The Journal of Infectious Diseases — Overview and Recent Developments in Influenza Treatment Options
  5. The Journal of Infectious Diseases — Evolving Patient Care Strategies for Influenza in the Aftermath of the COVID-19 Pandemic: A Position Statement
  6. The Journal of Infectious Diseases — Antiviral Strategies for Influenza Prevention and Management in Immunocompromised Patients
  7. The Journal of Infectious Diseases — Use of Influenza Antivirals to Prevent Transmission
  8. Overview and Recent Developments in Influenza Treatment Options
  9. Evolving Patient Care Strategies for Influenza in the Aftermath of the COVID-19 Pandemic: A Position Statement
  10. Antiviral Strategies for Influenza Prevention and Management in Immunocompromised Patients
  11. Viral Respiratory Pathogens Toolkit for Nursing Homes | LTCFs | CDC
  12. Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks
  13. Evaluation of Influenza Antiviral Prophylaxis for Long-term Care Residents: A Systematic Review and Meta-Analysis - PubMed

Original Source(s)

Related Content